About: Centro di Riferimento Oncologico

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Centro di Riferimento Oncologico Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Aviano, Italy

Attributes	Values
rdf:type	Item
description	istituto di ricovero e cura a carattere scientifico (it) healthcare organization in Aviano, Italy (en)
rdfs:label	Centro di Riferimento Oncologico (en) Centro di riferimento oncologico di Aviano IRCCS (it)
skos:prefLabel	Centro di Riferimento Oncologico (en) Centro di riferimento oncologico di Aviano IRCCS (it)
name	Centro di Riferimento Oncologico (en) Centro di riferimento oncologico di Aviano IRCCS (it)
ROR ID	wds:Q30281668-6AEE40D3-B90A-4BD8-B762-52F847D7283D
ROR ID	03ks1vk59
instance of	wds:Q30281668-685B1BC9-7576-4D79-B7A6-44C8679A2003 wds:Q30281668-78A4798E-D601-432B-ACEF-1BA5B01CE999
instance of	Istituto di ricovero e cura a carattere scientifico medical organization
country	wds:Q30281668-0BFBF218-7148-4912-930E-71018A1B47BC
country	Italy
Ringgold ID	wds:Q30281668-9FDAC079-68EB-4768-B26A-7C39FDB84641
Ringgold ID	9355
inception	wds:Q30281668-FCC5FBCA-9A1D-4EAA-8EC0-BA6BFCE5A084
inception	1981-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	CRO (en) Centro di Riferimento Oncologico di Aviano (it) Centro di riferimento oncologico di Aviano IRCCS (en)
located in the adm...erritorial entity	wds:Q30281668-B270CE1E-BF1D-4DA5-BAB7-A071B0287416
ISNI	wds:Q30281668-2FC4AF9C-CF13-4288-A9D0-AEFF9127766B
Quora topic ID	wds:Q30281668-05435CEA-C00C-493F-9297-001958D32C75
has subsidiary	wds:Q30281668-CB42E025-43C0-4FA6-882A-887F2508663C
member of	wds:Q30281668-6F913D52-C34A-4720-9A0B-2BAF3469432D
coordinate location	wds:Q30281668-036D11BD-D821-4A28-A959-D29EB7AF6EEA
official website	wds:Q30281668-DEC02A16-C389-41B8-892D-D1E558BD45D1
located in the adm...erritorial entity	Aviano
ISNI	0000000417579741
Quora topic ID	Centro-Di-Riferimento-Oncologico-Di-Aviano
has subsidiary	Biblioteca scientifica e per pazienti del Centro di Riferimento Oncologico di Aviano (CRO) IRCCS
member of	Netval Research Universities Network
coordinate location	POINT(12.564676 46.063349)
official website	http://www.cro.it/it/index.html
GRID ID	wds:Q30281668-12953891-B2EE-4B25-9FA6-D89230904AC5
parent organization	wds:Q30281668-FEB72795-52E8-455B-976B-35B947BD8C40
GRID ID	grid.418321.d
parent organization	Istituto di ricovero e cura a carattere scientifico
is owl:sameAs of	Centro di Riferimento Oncologico
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30281668
is pr:P3452 of	wdref:40339c3a22a6b3b973e991b0cd7306fdd86c4c52
is affiliation of	Mauro Mazzocut
is affiliation of	wds:Q59768303-B078175D-736D-484E-ACE1-F1DAF17CCBF8
is research site of	Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases Premenopausal Endocrine Responsive Chemotherapy Trial Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer An Efficacy Study Comparing Brigatinib Versus Alectinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Participants Who Have Progressed on Crizotinib Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma innovaTIL-01, Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant Vaccine Therapy in Treating Patients With Primary Stage II Melanoma Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Patients With ALK-Positive or ROS1-Positive Solid Tumors Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer Observational Study on Endometrial Stromal Tumors Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma Chemotherapy Plus Surgery in Treating Women With Breast Cancer Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
is research site of	wds:Q64188667-9AF92116-9C19-4B7B-A99A-49FC1045B10E wds:Q64626412-B764D843-B3E6-4BCB-9423-6DEF39B1BF4D wds:Q62031094-50AC0EC3-1A12-413D-97A1-D21D5823C01A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software